Compare NEOG & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | USPH |
|---|---|---|
| Founded | 1981 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1989 | 1992 |
| Metric | NEOG | USPH |
|---|---|---|
| Price | $6.05 | $75.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.83 | ★ $108.20 |
| AVG Volume (30 Days) | ★ 3.5M | 194.8K |
| Earning Date | 01-09-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 153.49 |
| EPS | N/A | ★ 2.38 |
| Revenue | ★ $886,886,000.00 | $750,948,000.00 |
| Revenue This Year | N/A | $19.53 |
| Revenue Next Year | $1.80 | $6.33 |
| P/E Ratio | ★ N/A | $31.57 |
| Revenue Growth | N/A | ★ 17.51 |
| 52 Week Low | $3.87 | $62.77 |
| 52 Week High | $13.51 | $99.35 |
| Indicator | NEOG | USPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 49.10 |
| Support Level | $5.82 | $71.77 |
| Resistance Level | $6.08 | $77.13 |
| Average True Range (ATR) | 0.32 | 2.83 |
| MACD | 0.00 | 1.00 |
| Stochastic Oscillator | 63.68 | 88.72 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.